Detalhe da pesquisa
1.
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.
Carcinogenesis
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366633
2.
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.
Int J Cancer
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630934
3.
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
PLoS Genet
; 17(6): e1009589, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34166362
4.
MYC determines lineage commitment in KRAS-driven primary liver cancer development.
J Hepatol
; 79(1): 141-149, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906109
5.
Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.
J Hepatol
; 77(3): 748-760, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378172
6.
DNA Methylation Profiling of Human Hepatocarcinogenesis.
Hepatology
; 74(1): 183-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33237575
7.
Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.
Semin Liver Dis
; 41(3): 321-330, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130336
8.
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.
J Hepatol
; 74(3): 700-715, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271159
9.
A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites.
Histopathology
; 74(5): 718-730, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636011
10.
The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments.
J Hepatol
; 79(1): 19-21, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088313
11.
Hypoxia is a key regulator in liver cancer progression.
J Hepatol
; 75(3): 736-737, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097995
12.
The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Cell Mol Neurobiol
; 34(2): 173-81, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24213248
13.
Lineage and ecology define liver tumor evolution in response to treatment.
Cell Rep Med
; 5(2): 101394, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38280378
14.
TRPC Channels Activated by G Protein-Coupled Receptors Drive Ca2+ Dysregulation Leading to Secondary Brain Injury in the Mouse Model.
Transl Stroke Res
; 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462831
15.
Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing.
Cell Rep
; 42(11): 113446, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980571
16.
Liver capsule: Molecular-based signatures in hepatocellular carcinoma.
Hepatology
; 63(6): 2018, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26856972
17.
Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma.
Front Immunol
; 13: 849958, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833139
18.
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNA.
Hepatol Commun
; 5(6): 1095-1105, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34141992
19.
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
Oncogene
; 40(1): 140-151, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097857
20.
Tumour evolution in hepatocellular carcinoma.
Nat Rev Gastroenterol Hepatol
; 17(3): 139-152, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31792430